Article
Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'Ivoire.
AIDS (London, England) - 1 Jul 2003
Adjé-Touré Christiane, Celestin Bilé, Hanson Debra, Roels Thierry H, Hertogs Kurt, Larder Brendan, Diomande Fabien, Peeters Martine, Eholié Serge, Lackritz Eve, Chorba Terence, Nkengasong John N
Abstract excerpt
OBJECTIVE: To determine the prevalence of genotypic and phenotypic antiretroviral (ARV) drug-resistant HIV-1 strains among patients with viral load rebound while receiving ARV therapy in Abidjan, Côte d'Ivoire. METHODS: Between August 1998 and April 2000, we selected all patients (n = 241) who had received ARV drug therapy for at least 6 months in the UNAIDS-Drug Access Initiative (DAI), in Abidjan. We analyzed...
Topics
- Adult
- Anti-HIV Agents
- Cote d'Ivoire
- Developing Countries
- Drug Resistance, Multiple, Viral
- Female
- Genotype
- HIV Infections
- HIV Protease Inhibitors